Evidence against the reversion of mutation in the Haemophilus influenzae phage HP1c1 by preinfection treatment of host cells or phage with MNNG.
N-Methyl-N'-nitrosoguanidine (MNNG) causes reversion of a temperature-sensitive mutation in a bacteriophage of Haemophilus influenzae if exposure to the mutagen takes place after infection but before lysis. However, neither pre-infection treatment of the phage DNA, host cells, or both will cause reversion. The reasons for this are discussed in relation to the somewhat different results in the Escherichia coli lambda phage system and in relation to error-prone repair and replication processes.
D001435:Bacteriophages / Q000187:drug effects / Q000235:genetics*; D004260:DNA Repair; D004279:DNA, Viral / Q000378:metabolism; D006193:Haemophilus influenzae / Q000235:genetics; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology*; D009154:Mutation / Q000187:drug effects*
D004279:DNA, Viral; D008769:Methylnitronitrosoguanidine